Follow
Anita Madir
Anita Madir
University of Zagreb School of Medicine
Verified email at mef.hr
Title
Cited by
Cited by
Year
Natural history of nonalcoholic fatty liver disease: implications for clinical practice and an individualized approach
I Grgurevic, K Podrug, I Mikolasevic, M Kukla, A Madir, EA Tsochatzis
Canadian Journal of Gastroenterology and Hepatology 2020 (1), 9181368, 2020
642020
Development, validation, and prognostic evaluation of a risk score for long-term liver-related outcomes in the general population: a multicohort study
M Serra-Burriel, A Juanola, F Serra-Burriel, M Thiele, I Graupera, E Pose, ...
The Lancet 402 (10406), 988-996, 2023
522023
Hepatitis C is now curable, but what happens with cirrhosis and portal hypertension afterwards?
I Grgurevic, T Bozin, A Madir
Clinical and experimental hepatology 3 (4), 181-186, 2017
372017
LiverScreen project: study protocol for screening for liver fibrosis in the general population in European countries
I Graupera, M Thiele, AT Ma, M Serra-Burriel, J Pich, N Fabrellas, ...
BMC public health 22 (1), 1385, 2022
172022
Validation of the new diagnostic criteria for clinically significant portal hypertension by platelets and elastography
K Podrug, V Trkulja, M Zelenika, T Bokun, A Madir, TF Kanizaj, J O’Beirne, ...
Digestive diseases and sciences 67 (7), 3327-3332, 2022
142022
Assessment of clinically significant portal hypertension by two‐dimensional shear wave elastography
I Grgurevic, A Madir, V Trkulja, T Bozin, G Aralica, K Podrug, I Mikolaševic, ...
European journal of clinical investigation 52 (6), e13750, 2022
142022
Epidemiological and clinical features of primary biliary cholangitis in two Croatian regions: a retrospective study
A Madir, T Božin, I Mikolašević, S Milić, D Štimac, M Mijić, ...
Croatian Medical Journal 60 (6), 494-502, 2019
132019
Prognostic factors in primary biliary cholangitis: a retrospective study of joint slovak and croatian cohort of 249 patients
J Gazda, S Drazilova, M Janicko, I Grgurevic, T Filipec Kanizaj, T Koller, ...
Journal of personalized medicine 11 (6), 495, 2021
72021
FibroScan-AST score predicts 30-day mortality or need for mechanical ventilation among patients hospitalized with COVID-19
M Zelenika, M Lucijanic, T Bokun, T Bozin, M Barisic Jaman, ...
Journal of clinical medicine 10 (19), 4355, 2021
62021
Infection as a predictor of mortality in decompensated liver cirrhosis: exploring the relationship to severity of liver failure
I Grgurevic, V Trkulja, T Bozin, A Madir, M Miletic, S Marusic, J Skrlin, ...
European journal of gastroenterology & hepatology 32 (11), 1458-1465, 2020
62020
Portal hypertension in patients with nonalcoholic fatty liver disease: Current knowledge and challenges
A Madir, I Grgurevic, EA Tsochatzis, M Pinzani
World Journal of Gastroenterology 30 (4), 290, 2024
52024
Steatosis assessment by controlled attenuation parameter in patients with compensated advanced chronic liver disease
I Grgurevic, N Salkic, A Madir, G Aralica
Liver Int 40, 1784-1785, 2020
52020
Use of biochemical parameters for non-invasive screening of oesophageal varices in comparison to elastography-based approach in patients with compensated advanced chronic liver …
F Pastrovic, A Madir, K Podrug, M Lucijanic, T Bokun, M Zelenika, ...
Biochemia medica 32 (2), 280-290, 2022
22022
Correction: LiverScreen project: study protocol for screening for liver fibrosis in the general population in European countries
I Graupera, M Thiele, AT Ma, M Serra-Burriel, J Pich, N Fabrellas, ...
BMC public health 23 (1), 923, 2023
12023
Validation of Baveno VII criteria for clinically significant portal hypertension by two-dimensional shear wave elastography
R He, C Liu, I Grgurevic, Y Guo, H Xu, J Liu, Y Liu, XY Wang, H Shi, ...
Hepatology International 18 (3), 1020-1028, 2024
2024
Improved Applicability and Diagnostic Accuracy of the Novel Spleen-Dedicated Transient Elastography Device for High-Risk Esophageal Varices
A Madir, M Barisic Jaman, M Milosevic, P Dinjar Kujundžić, I Grgurevic
Diagnostics 14 (7), 743, 2024
2024
LiverScreen project: study protocol for screening for liver fibrosis in the general population in European countries (vol 22, 1385, 2022)
I Graupera, M Thiele, AT Ma, M Serra-Burriel, J Pich, N Fabrellas, ...
BMC PUBLIC HEALTH 23 (1), 2023
2023
Correction:: LiverScreen project: study protocol for screening for liver fibrosis in the general population in European countries
JM Pericàs, I Graupera, M Thiele, AT Ma, M Serra-Burriel, J Pich, ...
BMC International Health and Human Rights 23, 2023
2023
LiverScreen project
I Graupera, M Thiele, AT Ma, M Serra-Burriel, J Pich, N Fabrellas, ...
2022
LiverScreen project:: study protocol for screening for liver fibrosis in the general population in European countries
JM Pericàs, I Graupera, M Thiele, AT Ma, M Serra-Burriel, J Pich, ...
BMC International Health and Human Rights 22, 2022
2022
The system can't perform the operation now. Try again later.
Articles 1–20